Outlook Therapeutics Inc
NASDAQ:OTLK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Outlook Therapeutics Inc
NASDAQ:OTLK
|
US |
|
V
|
VR Resources Ltd
SWB:5VR
|
CA |
|
Dorel Industries Inc
F:DO4B
|
CA |
|
X
|
XIIlab Co Ltd
KOSDAQ:189330
|
KR |
|
F
|
Filament Health Corp
NEO:FH
|
CA |
|
B
|
Bioretec Oy
OMXH:BRETEC
|
FI |
|
E
|
Ekobot AB (publ)
STO:EKOBOT
|
SE |
|
C
|
Chongqing Wangbian Electric Group Corp Ltd
SSE:603191
|
CN |
|
T
|
Taaleri Oyj
OMXH:TAALA
|
FI |
|
S
|
Southern Copper Corp
DUS:PCU
|
US |
|
P
|
Prestige Wealth Inc
NASDAQ:PWM
|
HK |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is OTLK's stock price target?
Not Available
OTLK doesn't have any price targets made by Wall Street professionals.
What is Outlook Therapeutics Inc's Revenue forecast?
Projected CAGR
154%
For the last 10 years the
compound annual growth rate for
Outlook Therapeutics Inc's revenue is
-12%.
The projected
CAGR
for the next 3 years is
154%.